Interferon and its Clinical Potential by D A J Tyrrell FRS MD FRCP FRcPath pp viii+ 104 illustrated £3.50 London: William Heinemann Medical 1976 Interferon has always been interesting academically, and hopes for its clinical application have fluctuated over the years. We are passing through a phase of cautious optimism, when some promising results have been reported for interferon therapy of patients with virus infections and tumours. Dr Tyrrell's short monograph begins with a historical account of the discovery of interferon by Alick Isaacs, his colleague at the National Institute for Medical Research, and Jean Lindenmann, now Professor of Microbiology in Zurich. It continues with a concise description of the main biological and biochemical properties of interferon and concludes with a review of the use of interferon in various clinical situations.
There is good evidence that interferon can be found at sites of virus infection in man. Sensitized lymphocytes stimulated by antigens (viral or nonviral) release a type of interferon distinct antigenically and in other ways from that produced by fibroblast cultures. Several interferon inducers, such as double-stranded polyribonucleotides, can protect experimental animals against potentially lethal virus infections, but the timing of the protection shows that other effects, notably macrophage stimulation, are also involved. Dr Tyrrell and his colleagues have demonstrated some protection of human volunteers against respiratory viruses by repeated intranasal administration of interferon. Work of others also shows that administration of large doses of interferon can be used to treat human patients with virus diseases. The doses required are close to therapeutic feasibility using efficient methods of interferon production with human leukocytes and superinduction with cultured cells. Studies carried out up to one year ago are listed in Tyrrell's book, along with information on sources of human interferon and tests for efficacy and safety. contains twenty-four chapters, each written by an expert in his field. The editor should be congratulated on having brought together so many authoritative accounts on a wide range of subjects. The opening chapter by Lipowski provides a balanced overview on what nowadays constitutes the field of psychosomatic medicine as a clinical and scientific discipline, and should be read especially by those who are still reluctant to acknowledge the importance of the relation between psychosocial and physical aspects of illness.
Succeeding chapters deal with such topics as animal research, psychophysiological work on electrodermal activity, biofeedback techniques, psychoendocrine relationships in affective disorders, the relation between life events and physical illness, and the concept of alexithymia.
Specific disorders are dealt with in up-to-date reviews on asthma, essential hypertension, ischaemic heart disease, peptic ulceration, anorexia nervosa, obesity and dermatology. Maher-Loughnan provides an account of the use of hypnosis and autohypnosis, and the last two chapters deal with approaching death and the care of the bereaved. Each chapter is followed by an extensive list of references.
The volume is exceptionally well produced and its wide scope and scientific and practical approach make it essential reading for anyone who wants to keep up to date in this rapidly expanding and important field of medical knowledge. The stated aims of Glaxo symposia are the presentation and discussion of new work, the meeting ofworkers with a common interest and publication of the proceedings. Prompt publication, especially in the active topical steroid field, is essential, and the two years' delay in publication in this case deprives the reader of a certain freshness expected of symposium proceedings.
A wide variety of unconnected effects of topical corticosteroids includes changes in the epidermis, the dermis, effect on melanin pigmentation, an absence of stimulation of epidermal cyclic AMP formation, the effect of steroids on prostaglandin activity by isolated epithelial cells and their effect on the pharmacology of inflammation. A single clinical study compares the response of psoriasis to dithranol and a potent topical steroid.
While all these topics are individually well presented and are a useful point of reference to the researcher, there is no semblance of cohesion and
